Cancer
What Did the Research Discover? Researchers investigated whether common blood tests could help identify hidden cancers in patients experiencing abdominal pain or bloating. Diagnosing cancer in people with these nonspecific symptoms is challenging, and while blood tests are commonly used in primary care, their effectiveness in predicting cancer risk was
Videos
Could managing your blood pressure actually help protect your memory? A 2023 study published in JAMA Network Open reveals a potential link between blood pressure medication and a lower risk of dementia in older adults. Researchers reviewed data from 17 studies involving over 34,000 participants—and
Health and Medical Research News
What Did the Research Discover? Researchers studied whether semaglutide, a medication commonly used for diabetes, could help protect kidney function and reduce heart-related risks in patients with type 2 diabetes and chronic kidney disease (CKD). The study included 3,533 participants who were randomly assigned to receive either semaglutide or
Videos
Could a simple blood test replace uncomfortable colonoscopies for many people? In July 2024, the FDA approved Shield, a new blood-based screening test developed by Guardant Health. This breakthrough test aims to make colorectal cancer screening easier, less invasive, and more accessible for adults 4
Videos
Can prediabetes really be reversed? This video explores a major 2021 study published in Diabetes by Fritsche and colleagues, revealing how matching treatment to a person’s risk level can change outcomes.
COPD
What did the research discover? This study evaluated the effectiveness of the CAPTURE screening tool in identifying undiagnosed, clinically significant chronic obstructive pulmonary disease (COPD) in primary care settings. The CAPTURE tool consists of five questions about symptoms and exposure, along with a lung function test for some patients. Researchers
FDA
For Immediate Release: July 29, 2025The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH ) products under the Controlled Substances Act (CSA). The FDA is specifically targeting
FDA
For Immediate Release: May 21, 2025The U.S. Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective and more affordable drugs for American patients, as part of its efforts to implement Executive Order Lowering Drug Prices by Once Again Putting Americans First.
FDA
For Immediate Release: May 13, 2025The U.S. Food and Drug Administration (FDA) today announced that it is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market. Unlike toothpaste with fluoride or fluoride rinses, these products are swallowed and ingested by infants and toddlers.
FDA
What Is a Recall? A recall is an action taken by a company to correct or remove from the market an FDA regulated product that violates U.S. laws and regulations. Recalls may be initiated voluntarily by a company, or at the request of the FDA. Recalls are important because
Videos
Can semaglutide help with weight loss even in people without diabetes? In this video, we explore new research on this weekly injection and its potential impact on body weight and overall health. Research by the Department of Pharmacy, Union Hospital, Tongji Medical College.
Cancer
What Did the Research Discover? Researchers studied whether women with hormone receptor-positive early breast cancer could safely pause their endocrine therapy to try to get pregnant. This treatment is usually taken for 5 to 10 years to lower the risk of cancer coming back, but pregnancy is not recommended during